drugset / Trial / NCT02412449

Relative Bioavailability of Two Formulations of AKB-6548 and the Food Effect of a New Tablet in Healthy Adult Subjects

NCT02412449

Phase 1 Completed 18 enrolled Akebia Therapeutics
RandomizedCrossoverOpen-labelOther

Summary

The primary purpose of this study is to compare the PK parameters of a single dose of a test tablet formulation of AKB-6548 relative to a single dose of the reference AKB-6548 tablet formulation, both treatments administered without food, and to compare the PK parameters of the test tablet formulation given under fed and fasted conditions.

Timeline

Start
2015-04
Primary completion
2015-04
Completion
2015-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Vadadustat Small molecule

Indications

No indication recorded.